Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fortis Healthcare Ltd - 532843 - Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, August 6, 2019 to, inter-alia, consider and approve un-audited financial results for the quarter ended June 30, 2019. Further, in continuation to our letter ref. FHL/SEC/2019-20 dated July 02, 2019 captioned 'Closure of Trading Window', it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till August 8, 2019. This is for your information and record please.
29-07-2019
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Shareholding for the Period Ended June 30, 2019

 Fortis Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here
11-07-2019
Bigul

Fortis Healthcare Ltd - 532843 - Statement Of Investor Complaints For The Quarter Ended June 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 019190 Name of the Signatory :- Sumit GoelDesignation :- Company Secretary and Compliance Officer
10-07-2019
Bigul

Fortis Healthcare Ltd - 532843 - Disclosure(S) Under Regulation 30 - Sale Or Disposal Of MSCL

 Dear Sir(s), This is in continuation of our intimation ref. FHL/SEC/2019-20 dated May 17, 2019 captioned sale or disposal of MSCL and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Fortis Healthcare International Limited ('FHIL'), a wholly owned subsidiary of Fortis Healthcare Limited ('FHL' or 'the Company'), which is incorporated in Mauritius, has consummated the Proposed Transaction of sale of the entire shareholding held by FHIL in The Medical and Surgical Centre Limited ('MSCL') [renamed as C-Care (Mauritius) Ltd.], representing 28.89% (164,670,801 shares) holding of the total issued and paid up equity share capital of MSCL, with CIEL Limited, CIEL Healthcare Limited (collectively referred to as 'CIEL'). The entire stake of FHIL in MSCL is now divested. The detailed disclosure as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith as Annexure A. This is for your information and records please.
08-07-2019
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Fortis Healthcare Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
08-07-2019
Bigul

Fortis Healthcare Ltd - 532843 - Proceedings And Voting Result Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 With reference to the Postal Ballot Notice dated May 24, 2019 wherein the following resolution(s) were proposed to be passed by way of postal ballot as well as through e-voting: - 1. Special Business - Approval of Disinvestment of shareholding in M/s. The Medical and Surgical Centre Ltd, an indirect associate company, held through a wholly owned subsidiary, Fortis Healthcare International Limited. (Special Resolution) 2. Special Business - Approval of Modification of terms of Non-Convertible Bonds (NCBs) issued by subsidiary companies. (Special Resolution) Please find enclosed results of postal ballot in prescribed format along with Scrutinizer's Report as 'Annexure 1'. Please note that the resolutions have been passed with requisite majority. This is for your information and records.
08-07-2019
Bigul

Fortis Healthcare Ltd - 532843 - Closure of Trading Window

 With reference to the provisions of Policy / Code of Conduct for Prevention of Insider Trading, the "Trading Window" for dealing in shares of the Company is closed from July 1, 2019 till further notice. This is for your information and records please.
02-07-2019
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI LODR")

 Pursuant to Regulation 23(9) of SEBI LODR, as amended, please find enclosed disclosures of related party transactions on a consolidated basis in the format specified in the relevant accounting standards for a half year ended March 31,2019. This is for your information and records please.
21-06-2019
Bigul

Fortis Healthcare Ltd - 532843 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI LODR")

 Pursuant to Regulation 23(9) of SEBI LODR, as amended, please find enclosed disclosures of related party transactions on a consolidated basis in the format specified in the relevant accounting standards for a half year ended March 31,2019. This is for your information and records please.
21-06-2019
Bigul

Fortis Healthcare turns focus on cost control and consolidation

 This is a departure from Fortis' earlier plans that entailed, for example, retail expansion of its diagnostics arm SRL, especially in the southern markets
19-06-2019
Next Page
Close

Let's Open Free Demat Account